References
- 1. MICHELS AW., GOTTLIEB PA. Autoimmune polyglandular syndromes. Nat Rev Endocrinol. 2010; 6(5):270–7.
- 2. KAHALY GJ., FROMMER L. Polyglandular autoimmune syndromes. J Endocrinol Invest. 2018; 41(1):91–98.
- 3. HUBER A., MENCONI F., CORATHERS S., JACOBSON EM., TOMER Y. Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr Rev. 2008; 29(6):697–725.
- 4. GRUBIC Z., ROJNIC PUTAREK N., MASKALAN M., ZUNEC R., STINGL JANKOVIC K., BUREK KAMENARIC M., et al. Human Leukocyte Antigen class II polymorphisms among Croatian patients with type 1 diabetes and autoimmune polyglandular syndrome type 3 variant. Gene. 2018; 674:93–97.
- 5. D’ANTONA L., et al. Prevalence of undiagnosed diabetes in rheumatoid arthritis: an OGTT Study. Medicine (Baltimore). 2016; 95(7):e2552.
- 6. DOUGADOS M., SOUBRIER M., ANTUNEZ A., BALINT P., BALSA A., BUCH MH., et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis. 2014; 73(1):62–8.
- 7. NAIK RG., BROOKS-WORRELL BM., PALMER JP. Latent autoimmune diabetes in adults. J Clin Endocrinol Metab. 2009; 94(12):4635–44.